Fluctuating thyroid function depending on the balance between stimulating and blocking types of TSH receptor antibodies: a case report.
暂无分享,去创建一个
H. Sakahara | J. Konishi | R. Takeuchi | K. Kasagi | T. Misaki | K. Endo | A. Hidaka | S. Miyamoto
[1] T. Aizawa,et al. Disappearance of thyrotropin-blocking antibodies and spontaneous recovery from hypothyroidism in autoimmune thyroiditis. , 1992, The New England journal of medicine.
[2] O. Sadeh,et al. Changes in stimulating and blocking TSH receptor antibodies in a patient undergoing three cycles of transition from hypo to hyper‐thyroidism and back to hypothyroidism , 1992, Clinical endocrinology.
[3] K. Kuma,et al. Thyroid-stimulating antibodies and thyroid stimulation-blocking antibodies during the pregnancy and postpartum period: a case report. , 1992, Thyroid : official journal of the American Thyroid Association.
[4] N. Takasu,et al. Graves' Disease Following Hypothyroidism Due To Hashimoto's Disease: Studies Of Eight Cases , 1990, Clinical endocrinology.
[5] S. Nagataki,et al. Follow‐Up Study Of Thyroid Stimulating‐Blocking Antibodies In Hypothyroid Patients , 1990, Clinical endocrinology.
[6] N. Amino,et al. Low prevalence of thyrotropin receptor antibody in primary hypothyroidism in Japan. , 1990, The Journal of clinical endocrinology and metabolism.
[7] S. Fukata,et al. Transient postpartum hypothyroidism caused by thyroid-stimulation-blocking antibody , 1990, The Lancet.
[8] J. Mckenzie,et al. Transient neonatal hypothyroidism: characterization of maternal antibodies to the thyrotropin receptor. , 1990, The Journal of clinical endocrinology and metabolism.
[9] H. Hatabu,et al. PRESENCE OF BOTH STIMULATING AND BLOCKING TYPES OF TSH‐RECEPTOR ANTIBODIES IN SERA FROM THREE PATIENTS WITH PRIMARY HYPOTHYROIDISM , 1990, Clinical endocrinology.
[10] S. Nagataki,et al. Development of spontaneous hypothyroidism in patients with Graves' disease treated with antithyroidal drugs: clinical, immunological, and histological findings in 26 patients. , 1989, The Journal of clinical endocrinology and metabolism.
[11] A. Miyauchi,et al. Coexistence of thyroid-stimulating and thyroid-blocking antibodies in a patient with Graves' disease who had transient hypothyroidism. , 1988, The American journal of medicine.
[12] H. Hatabu,et al. Inhibition of thyrotropin-stimulated iodide uptake in FRTL-5 thyroid cells by crude immunoglobulin fractions from patients with goitrous and atrophic autoimmune thyroiditis. , 1988, The Journal of clinical endocrinology and metabolism.
[13] H. Kitaoka,et al. DEVELOPMENT OF HYPERTHYROIDISM FOLLOWING PRIMARY HYPOTHYROIDISM: A CASE REPORT WITH CHANGES IN THYROID‐RELATED ANTIBODIES , 1988, Clinical endocrinology.
[14] J. Konishi,et al. Inhibition of thyrotropin-induced growth of rat thyroid cells, FRTL-5, by immunoglobulin G from patients with primary myxedema. , 1987, The Journal of clinical endocrinology and metabolism.
[15] J. Konishi,et al. A sensitive and practical assay for thyroid-stimulating antibodies using crude immunoglobulin fractions precipitated with polyethylene glycol. , 1986, The Journal of clinical endocrinology and metabolism.
[16] J. Konishi,et al. Primary myxedema with thyrotrophin-binding inhibitor immunoglobulins. Clinical and laboratory findings in 15 patients. , 1985, Annals of Internal Medicine.
[17] P. Carayon,et al. Heterogeneity of the Graves' immunoglobulins directed toward the thyrotropin receptor-adenylate cyclase system. , 1983, The Journal of clinical endocrinology and metabolism.
[18] P. Vitti,et al. Monoclonal antibodies to the thyrotropin receptor: stimulating and blocking antibodies derived from the lymphocytes of patients with Graves disease. , 1982, Proceedings of the National Academy of Sciences of the United States of America.